Your shopping cart is currently empty

Anticanceragent 292 (Compound P4) is a photosensitizer targeting melanoma. It exhibits good biocompatibility in the absence of light and, when exposed to light, induces apoptosis and partial necrosis of B16-F10 cells by disrupting lysosomal membranes. Furthermore, Anticanceragent 292 not only directly kills tumor cells through generated ROS but also induces immunogenic cell death (ICD), leading to antitumor immune responses. This compound is applicable for research in photodynamic therapy for melanoma.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Anticanceragent 292 (Compound P4) is a photosensitizer targeting melanoma. It exhibits good biocompatibility in the absence of light and, when exposed to light, induces apoptosis and partial necrosis of B16-F10 cells by disrupting lysosomal membranes. Furthermore, Anticanceragent 292 not only directly kills tumor cells through generated ROS but also induces immunogenic cell death (ICD), leading to antitumor immune responses. This compound is applicable for research in photodynamic therapy for melanoma. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.